Norrman E, Plaschke P, Björnsson E, Rosenhall L, Lundbäck B, Jansson C, Lindholm N, Boman G
Department of Pulmonary Medicine and Allergology, University Hospital of Northern Sweden, Umeå, Sweden.
Respir Med. 1998 Mar;92(3):480-7. doi: 10.1016/s0954-6111(98)90295-5.
Studies have suggested that there is a higher prevalence of asthma in northern Sweden than in southern Sweden. Bronchial hyper-responsiveness (BHR) has been shown to be associated with asthma. The aim of this study was to explore the prevalence of bronchical hyper-responsiveness in different parts of Sweden. As part of the European Community Respiratory Health Survey (ECRHS), interviews, skin prick tests, lung function tests and methacholine provocation tests of the airways were performed in 1448 randomly selected subjects in southern, central and northern Sweden. The Mefar dosimeter was used according to the ECRHS protocol. The responsiveness was calculated both as the PD20 and as the dose response slope (DRS). BHR was defined as a PD20 of < or = 1.6 mg. Atopy was defined as at least one skin prick test of > or = 3 mm. The prevalence of BHR was 12.7%, 10.6% in men and 15.0% in women. No difference in prevalence was found between the three different regions of Sweden. The prevalence of BHR was higher in women than in men and higher in smokers than in non-smokers. Using multiple logistic regression, with BHR as the dependent variable, atopy, being female, having a low FEV1 (% predicted) and smoking (both own and passive) increased the odds of having BHR, while age and the region of Sweden did not influence BHR. Defining BHR as a PD20 of < or = 1.0 mg or a PD20 of < or = 2.0 mg did not change this. Multiple regression using log DRS as the dependent variable produced the same result. Both BHR and increasing DRS were associated with self-reported wheezing, attacks of shortness of breath during the daytime at rest or after strenuous activity, being awakened by a feeling of tightness in the chest or an attack of shortness of breath. In subjects without self-reported asthma, BHR was associated with self-reported wheezing and attacks of shortness of breath after strenuous activity. In conclusion, we found that the prevalence of BHR in the three investigated areas was 12.7%. We found a trend towards a higher prevalence of BHR in the most northerly of the study areas, but the difference between the areas was not statistically significant. BHR and DRS were associated with atopy, smoking, female sex and FEV1 (% predicted). The reporting of symptoms from the airways was associated with the degree of bronchical responsiveness.
研究表明,瑞典北部哮喘的患病率高于瑞典南部。支气管高反应性(BHR)已被证明与哮喘有关。本研究的目的是探讨瑞典不同地区支气管高反应性的患病率。作为欧洲共同体呼吸健康调查(ECRHS)的一部分,对瑞典南部、中部和北部随机选取的1448名受试者进行了访谈、皮肤点刺试验、肺功能测试和气道乙酰甲胆碱激发试验。根据ECRHS方案使用Mefar剂量仪。反应性以PD20和剂量反应斜率(DRS)计算。BHR定义为PD20≤1.6毫克。特应性定义为至少一次皮肤点刺试验≥3毫米。BHR的患病率为12.7%,男性为10.6%,女性为15.0%。瑞典三个不同地区的患病率没有差异。BHR的患病率女性高于男性,吸烟者高于非吸烟者。以BHR为因变量进行多因素logistic回归分析,特应性、女性、FEV1(预测值%)低和吸烟(主动吸烟和被动吸烟)增加了患BHR的几率,而年龄和瑞典地区对BHR没有影响。将BHR定义为PD20≤1.0毫克或PD20≤2.0毫克并不会改变这一结果。以log DRS为因变量进行多元回归分析得到相同结果。BHR和DRS增加均与自我报告的喘息、白天休息时或剧烈活动后气短发作、因胸部紧迫感或气短发作而醒来有关。在没有自我报告哮喘的受试者中,BHR与自我报告的喘息和剧烈活动后气短发作有关。总之,我们发现三个调查地区的BHR患病率为12.7%。我们发现研究区域最北部的BHR患病率有升高趋势,但各地区之间的差异无统计学意义。BHR和DRS与特应性、吸烟、女性性别和FEV1(预测值%)有关。气道症状的报告与支气管反应性程度有关。